Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Jul 2026 for Biomark Diagnostics Inc., €4,343.
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
James Arthur Lavender: trading record in brief
All filings by James Arthur Lavender on record concern Biomark Diagnostics Inc. We count 2 filings; the first trade dates from 22 December 2025 and the latest from 16 July 2026.
No open-market sale appears; the market trades are 1 purchase worth €4,343. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and no sales on the market.
On 16 July 2026 came the latest disclosure, an open-market purchase for €4,343 in Biomark Diagnostics Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Arthur Lavender
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
12,700 shares@ CA$0.55Common SharesTSXSEDI:4753282
1 of 1 declaration
